US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist
  • 51.300
  • -0.720-1.38%
Close Jul 2 16:00 ET
  • 51.500
  • +0.200+0.39%
Post 17:50 ET
6.53BMarket Cap21.29P/E (TTM)

Halozyme Therapeutics Key Stats

Halozyme Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 7, 2024

Revenue(YoY)

195.88M

+20.81%
EPS(YoY)

0.60

+106.90%

Buy

Jul 2, 2024

Halozyme Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 273.179M--
--2024/Q2-- / 208.900M--
May 7, 20242024/Q1195.879M / 199.649M--
Feb 20, 20242023/Q4230.039M / 231.143M--
Nov 6, 20232023/Q3216.033M / 216.109M--
Aug 8, 20232023/Q2221.038M / 199.951M--
May 9, 20232023/Q1162.143M / 175.517M--
Feb 21, 20232022/Q4181.496M / 192.055M--
Nov 8, 20222022/Q3208.976M / 191.171M--
Aug 9, 20222022/Q2152.365M / 156.000M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 273.179M--
--2024/Q2-- / 208.900M--
May 7, 20242024/Q1195.879M / 199.649M--
Feb 20, 20242023/Q4230.039M / 231.143M--
Nov 6, 20232023/Q3216.033M / 216.109M--
Aug 8, 20232023/Q2221.038M / 199.951M--
May 9, 20232023/Q1162.143M / 175.517M--
Feb 21, 20232022/Q4181.496M / 192.055M--
Nov 8, 20222022/Q3208.976M / 191.171M--
Aug 9, 20222022/Q2152.365M / 156.000M--

Unlock Free Earnings Estimates

Halozyme Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Jul 2, 2024

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg